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Abstract: Upper airway abnormalities increase the risk of pediatric morbidity in infants.
A multidisciplinary approach to obstructive sleep apnea syndrome (OSAS) poses challenges to
clinical practice. The incidence and causes of OSA are poorly studied in children under 2 years
of age. To fill this gap, we performed this retrospective observational study to determine the
causes of obstructive sleep apnea (OSA) in children admitted to our hospital between January 2016
and February 2018, after a brief unexplained event (BRUE) or for OSA. We reviewed the medical
charts of 82 patients (39 males; BRUE n = 48; OSAS n = 34) and divided them into two age
groups: < 1 year old (1–12 months; n = 59) and >1 year old (>12–24 months; n = 23). Assessment
included nap polysomnography, multichannel intraluminal impedance-pH, and nasopharyngoscopy.
Sleep disordered breathing was comparable between the two groups. Omega-shaped epiglottis,
laryngomalacia, and nasal septum deviation were more frequent in the younger group, and nasal
congestion in older group. Tonsillar and adenoidal hypertrophy was more frequent in the older group,
while laryngomalacia and gastroesophageal reflux was more frequent in the younger group. Tonsil and
adenoid size were associated with grade of apnea-hypopnea index severity in the older group, and
laryngomalacia and gastroesophageal reflux in the younger group. The main causes of respiratory
sleep disorders differ in children before or after age 1 year. Our findings have potential clinical utility
for assessing the pathophysiology of obstructive sleep disordered breathing in patients less than
2 years old.
Keywords: brief resolved unexplained event; gastro-esophageal reflux; infants; laryngomalacia;
obstructive sleep disordered breathing; polysomnography
1. Introduction
Obstructive sleep apnea syndrome (OSAS) describes a spectrum of abnormal breathing patterns
during sleep, characterized by snoring and respiratory effort secondary to increased upper airway
resistance and pharyngeal collapsibility, with alterations of normal oxygenation, ventilation, and sleep
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architecture. Intermittent desaturation during sleep has multiorgan implications from childhood to
adulthood [1,2]. The estimated frequency of OSAS is between 1% and 5% in preschool and school
children [2].
Snoring and noisy breathing are OSAS-related symptoms during the first 2 years of life, followed
by apnea, sleep movement, oral breathing, and recurrent awakenings. These symptoms are often
related to micrognathia [3]. Micrognathia and body position reduce muscular tone, increase pharyngeal
collapse, and reduce upper airway volumes. They are key factors in night-time sleep disorders [4].
Based on pressure transducer measurement, the main sites of upper airway obstruction are retro-palatal
(52%) and retro-glossal (48%) [5]. Neck position is another important factor in airway collapsibility [6].
Restriction of the upper airways and negative pressure during inhalation are also implicated in upper
airway collapse.
Obstructive sleep apnea (OSA) is a cause of apparent life-threatening events (ALTE), brief resolved
unexplained events (BRUE), and sudden infant death syndrome (SIDS). A reduction in airways
size due to mucosal edema and an increase in adenoid size from bacterial or viral infections have
been observed in children aged 6 weeks and older [7]. Another cause of upper airway obstruction
is laryngeal chemoreflex, a physiological protective mechanism that prevents inhalation of liquids.
Gastroesophageal reflux (GER) and apnea may share a common relationship [8].
Nocturnal polysomnography (sleep study) is the only diagnostic technique shown to quantitate
the ventilatory and sleep abnormalities associated with sleep disordered breathing (SDB), and it is
currently the gold standard [2]. ALTE is not considered an event that requires PSG. Cardiorespiratory
monitoring in children who snore is problematic [9]. Katz et al. distinguished different types of SDB
during the first 2 years of life: periodic breathing, apnea of prematurity, and central apneas. However,
OSAS has been poorly investigated in very young children [4].
The incidence of OSA peaks between age 2 and 8 years; a plausible explanation is the increase in
the size of lymphoid tissue of the neck in this age group [10]. Importantly, however, the incidence and
causes of OSAS are underinvestigated in young infants (<2 years of age) [11], even when associated
with a history of ALTE/BRUE [3]. Nevertheless, early intervention is life-saving in young children with
OSA or can reduce complications later on [3]. Greenfeld et al. found that the morbidity of OSAS is more
severe in infants [12] and our group found that the parents of children with a history of ALTE/BRUE
reported more sleep disorders than controls [13]. Furthermore, Guilleminault el al. observed that
ALTE/BRUE in newborns were more prevalent in children with micrognathia, retrognathia, and bifid
uvula [14], all anatomic anomalies that increase the risk of OSAS [3]. Piteo et al. reported that SDB at
age 6–18 months increases the risk of hyperactivity at age 7 years [15].
With this study we evaluated the multidisciplinary approach to OSA in young children, and the
role of pediatric sleep specialists, otolaryngologists, and gastroenterologists in particular. We reviewed
the medical charts of children at the time of admission to our institution and analyzed the findings
from ENT assessment, gastroenterology evaluation (GER), and PSG. There are data suggesting that
children younger than 1 year have different pathophysiology of OSA and BRUE than those having
more than 1 year of age, the aim of the study was to investigate characteristic and severity based on a
multidisciplinary approach.
2. Subjects and Methods
We performed this retrospective observational study at the Pediatric Clinic of the University
of Insubria (Italy), with the collaboration of the Otorhinolaryngology and Gastroenterology Service.
The protocol was approved by the Institutional Ethics Committee of the University of Insubria
(n. 110/2017).
Exclusion criteria were age <1 month, central apneas at PSG, intercurrent infection,
genetic syndromes, or neuromuscular disorders. Inclusion criteria were age between 1 month
and 2 years, hospitalization for suspected OSAS (reported snoring, sleep apneas, oral breathing in
response to nasal loading,) or after a BRUE. We assumed that a BRUE can be a manifestation of OSA in
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very young infants. Assessment included nap PSG, upper airway fibroscopy, and multichannel pH
intraluminal impedanceometry. Children positive at PSG (Apnea-Hypopnea Index [AHI] > 1 event/h)
underwent subgroup analysis.
The study population was 82 children (39 males) with a history of BRUE or OSA admitted to
our institution between January 2016 and February 2018. Two age groups were formed: age <1 year
(1–12 months; 72%) and age > 1 year (13–24 months; 28%).
2.1. Nap Polysomnography
PSG was performed by sleep recording with an E series instrument (Compumedics P/L,
Melbourne, Australia). The machine records nasal flow pressure (measured with nasal cannulas),
nasal flow (thermistor), chest and abdominal movement (inductive bands) (Compumedics
P/L), SpO2 (pulse oximetry measured at a rate of 1 sample/s) and ECG (set to 500 Hz).
Carbon dioxide was monitored using transcutaneous CO2 (TcCO2). Sleep staging was based on
data from electroencephalogram (EEG; channels: C4-M1, C3-M2, O1-M2, O2-M1, F4-M1, F3-M2),
electro-oculogram (EOG; ROC/M1, LOC/M2), and submental electromyogram (EMG). The sleep
machine included video and audio recordings and a position sensor.
Nap PSG was recorded between two baby feedings, starting not earlier than 30 min after a meal.
The child lay on his back in his bed. If the recording was less than 2 h, the study continued until the
next feed.
The sleep staging criteria refer to those for 2-month-old infants; other published criteria were used
for staging sleep in children <6 months [16,17]. An experienced physician assigned the sleep score (LN).
The OSAS score was mild if the obstructive apnea-hypopnea index (AHI) was 1 to 5 episodes/ h;
moderate if the AHI was 5–10 episodes/h, and severe if the AHI was >10 episodes/h [18].
2.2. Multichannel Intraluminal Impedance-pH
Multichannel intraluminal impedance-pH monitoring (MII-pH) was used to determine reflux.
The method has been used to detect liquid, gaseous or mixed reflux, acid reflux or weakly alkaline reflux.
2.3. Nasopharyngoscopy
Laryngomalacia was evaluated by nasopharyngoscopy. Children with moderate–severe OSA or
reported snoring, nasal loading, and oral breathing underwent direct laryngoscopy under general
anesthesia to reveal airway injury [4]. Optical fiber laryngoscopy was performed, using a flexible
Pentax FNL-10 RP3 rhinolaryngoscope (Pentax, Tokyo, Japan) (3.4 mm).
2.4. Statistical Analysis
Statistical analysis was performed using StatView software. The Mann-Whitney test and the
Kruskal-Wallis test were used to compare continuous measures and the two-way contingency test
(chi-square test) to analyze frequencies. Statistical significance was set at p < 0.05.
3. Results
Table 1 presents the sample characteristics by age group: 59 infants (age 1 to 12 months) and 23
children (age 13 to 24 months). In the younger group, 19% were hospitalized for OSAS and 81% for
a BRUE. In the older group, all were hospitalized for OSAS.
Table 2 presents the PSG findings for the two age groups. In the older group, the mean peripheral
capillary oxygen saturation (SpO2) (p = 0.043) and the minimum SpO2 (%) were lower in the older group,
and the AHI (events/h) was higher, but neither was significant (p = NS). The distribution of AHI
severity showed no statistically significant difference between the two age groups (p = 0.067).
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Table 1. Characteristics of the sample based on clinical diagnosis at admission and age.
Characteristic Age 1 Month–12 Months Age 13 Months–24 Months
Total-No. (%) 59 (72) 23 (28)
Diagnosis at Admission
OSAS 11 (19) 23 (100)
BRUE 48 (81) -
Low Risk 12 (25) -
High Risk 36 (75) -
BRUE denotes brief resolved unexplained events; OSAS: obstructive sleep apnea syndrome.
Table 2. Polysomnography findings.
Sleep Respiratory Parameters Total (n = 82) Age 1–12 Months(n = 59)
Age 13–24 Months
(n = 23) Mann-Whitney Test p-Value
Mean SpO2 (%) 97.8 ± 1.2 98.0 ± 1.0 97.0 ± 1.5 0.043
Min SpO2 (%) 89.0 ± 6.3 89.0 ± 5.0 87.0 ± 6.5 NS
AHI (events/h) 3.8 ± 7.1 3.6 ± 6.3 5.7 ± 7.7 NS
AHI Severity No. (%) No. (%) No. (%) Two-Way Contingency TableChi Square test (p-value)
Mild 42 (51.2) 33 (55.9) 10 (43.5)
Moderate 21 (25.6) 16 (27.1) 6 (26.1)
Severe 19 (23.2) 10 (17.0) 7 (30.4) 5.354 (p = 0.067)
SpO2 denotes oxygen saturation; AHI: apnea-hypopnea index.
Table 3 presents the overall otorhinolaryngology and gastroenterology findings by age group.
The frequency of distribution of laryngeal, nasal, and turbinate abnormalities was statistically different
(p < 0.001). In particular, omega-shaped epiglottis, laryngomalacia, and nasal septum deviation were
more frequent in the younger group, and nasal congestion in the older group. Adenoid and tonsillar
hypertrophy were more frequent in the older group (p < 0.001). GER was more common in the
younger group.







Chi Square Test (p-Value)
Omega-Shaped Epiglottis 12 (14.6) 11 (18.6) 1 (4.3)
Laryngomalacia 13 (15.9) 12 (20.3) 1 (4.3)
Choanal Atresia 1 (1.2) 0 (0.0) 1 (4.3)
Nasal Congestion 10 (12.2) 6 (10.2) 4 (17.4)
Nasal Septum Deviation 3 (3.7) 3 (5.1) 0 (0.0)
Turbinate Hypertrophy 10 (12.2) 7 (11.9) 3 (13.0) 27.088 (p < 0.001)
Gastroesophageal Reflux 34 (41.5) 30 (50.8) 4 (17.4)
Adenoid Hypertrophy 33 (38.0) 13 (22.0) 20 (87.0)
Grade 1 11 (33.3) 9 (69.2) 2 (10) 26.7
Grade 2 9 (27.3) 2 (15.4) 7 (35)
Grade 3 9 (27.3) 1 (7.7) 8 (40)
Grade 4 4 (12.1) 1 (7.7) 3 (15) 76.092 (p < 0.001)
Tonsillar Hypertrophy 27 (32.9) 10 (16.9) 17 (73.9)
Grade 1 11 6 (60) 5 (29.4)
Grade 2 9 3 (30) 6 (35.3)
Grade 3 6 1 (10) 5 (29.4)
Grade 4 1 0 (0) 1 (5.9) 26.356 (p < 0.001)
Table 4 presents the frequency (number and %) of laryngomalacia, adenoidal and tonsillar
hypertrophy, GER (bold), and grade of AHI severity (mild, moderate, severe) in the total sample and
the two age groups. Tonsillar and adenoidal hypertrophy and laryngomalacia were more frequent in
the older group, while GER was more frequent in the younger group.
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Table 4. Frequency (number and percentage) of laryngomalacia, adenoid, and tonsillar hypertrophy,
and gastroesophageal reflux in the total sample (bold) and subgroups, and grade of apnea-hypopnea
index severity (mild, moderate, severe).






Chi Square Test (p-Value)
Laryngomalacia-No. (%) 12 (14.6) 11 (18.6) 1 (4.3)
Mild AHI–No. (% Mild/Total
Mild) 7 (16.7) 6 (18.2) 1 (10)
Moderate AHI–No. (% Moderate
/Total Moderate) 0 (0) 0 (0) 0 (0)
Severe AHI–No. (% Severe /Total
Severe) 5 (26.3) 5 (50.0) 0 (0) NC
Adenoid Hypertrophy-No. (%) 33 (40.2) 13 (22.0) 20 (87.0)
Mild AHI–No. (% Mild /Total
Mild) 12 (28.6) 7 (21.2) 7 (70.0)
Moderate AHI–No. (% Moderate
/Total Moderate) 9 (42.9) 2 (12.5) 6 (100)
Severe AHI–No. (% Severe /Total
Severe) 7 (36.8) 4 (40.0) 4 (57.1) 25.610 (<0.001)
Tonsillar Hypertrophy-No. (%) 27 (32.9) 10 (16.9) 17 (73.9)
Mild AHI–No. (% Mild /Total
Mild) 10 (23.8) 6 (18.2) 5 (50)
Moderate AHI–No. (% Moderate
/Total Moderate) 8 (38.1) 2 (12.5) 6 (100)
Severe AHI–no. (% Severe /Total
Severe) 6 (32.6) 3 (30.0) 3 (42.9) 22.315 (p < 0.001)
Gastroesophageal Reflux-No. (%) 34 (41.5) 30 (50.8) 5 (21.7)
Mild AHI (% Mild /Total Mild) 19 (45.2) 17 (51.5) 2 (20)
Moderate AHI–No. (% Moderate
/Total Moderate) 11 (52.4) 9 (56.3) 2 (20)
Severe AHI–No. (% Severe /Total
Severe) 5 (26.3) 4 (40.0) 1 (10) 1.047 (p = NS)
Total 79.889 (p < 0.001)
AHI denotes apnea-hypopnea index; NC: not computable.
Analysis of AHI grade (mild, moderate, severe) in relation to clinical findings (laryngomalacia,
adenoidal and tonsillar hypertrophy, and GER) showed that tonsillar and adenoid size was associated
with AHI severity in the older age group, while laryngomalacia and GER were associated with AHI
severity in the younger age group (Table 4).
4. Discussion
Obstructive sleep apnea (OSA) is a serious problem in children. OSAS in young children aged 1–23
months of age is multifactorial, and requires evaluation and treatment of the abnormalities underlying
upper airway obstruction during sleep. Polysomnography is the gold standard for diagnosing OSAS
in infants, and endoscopy is a useful tool for characterizing the severity of upper airway collapse [18].
Katidis et al., in their review of 159 articles on SDBs in children aged 1–23 months, underlined the
importance of a multidisciplinary approach to diagnosis and treatment [18].
To our best knowledge, ours is the only study that examines OSA in very young children. In our
non-syndromic patients aged between 1 and 12 months, BRUE (mainly high-risk) were the most
common clinical manifestation, whereas symptoms suggesting OSA were less frequent. In patients
aged 13 to 24 months, the only clinical presentation was symptoms suggesting OSAS. The AHI severity
was comparable between the two age groups. Upper airway endoscopy showed a difference in the
frequency of ENT anomalies: omega-shaped epiglottis, laryngomalacia, and nasal septum deviation
were more frequent in the younger group, and nasal congestion in the older group. Adenoidal and
tonsillar hypertrophy and severity were more prevalent in the older group. GER was often observed
in the younger group. Finally, we found that tonsillar and adenoid size was associated with AHI
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severity in the older children, while laryngomalacia and GER were associated with AHI severity in the
younger children.
A BRUE may be the first clinical sign of OSA. One study reported that BRUE may be
predictive of the development of SDB and malocclusion, highlighting the importance of long-term
follow-up [19]. These results suggest that children with a history of BRUE should be evaluated for
OSA at PSG. Furthermore, infants with a history of BRUE require a baseline PSG on which to base
clinical recommendations.
Data from 770 infants in the Edmonton sub-cohort of the Canadian Healthy Infant Longitudinal
Study (CHILD) identified four SDB phenotypes during the first 2 years of life: no SDB, early-onset SDB
(15.7%) with peak symptoms at 9 months, late-onset SDB (14.2%) with peak symptoms at 18 months, and
persistent SDB (5.3%) with symptoms from 3 to 24 months [3]. Rhinitis was associated with all three SDB
symptom trajectories [20]. During the first 2 years of life, the causes of OSAS are mainly anomalies of
upper airway anatomy (laryngomalacia, choanal atresia, macroglossia, and craniofacial malformations
in syndromic patients). Differently, upper respiratory tract obstruction secondary to hypertrophy of the
lymphoid tissue of the neck was reported to begin at 2 years of age [10]. Consistent with our findings,
an early survey showed that laryngomalacia and omega-shaped epiglottis were associated with OSAS
in infants aged < 1 year- [21].
Multichannel intraluminal impedance-pH monitoring (MII-pH) allows for the detection of liquid,
gas or mixed reflux, acidic or weakly alkaline reflux [22,23]. Recent data have shown an association
between atypical (extra-esophageal) symptoms and non-acid reflux. This finding suggests that non-acid
reflux may be significant in childhood. Non-acid reflux accounted for 48% of total reflux in 25 infants
with apnea or a history of BRUE [24] and apnea of prematurity [25].
According to a NICE report, signs of GER are less frequent in infants aged 1–2-years [26] because
they tend to disappear physiologically after 1 year of age [26]. In brief, upper airway inflammation,
laryngitis, reduced laryngo-pharyngeal reflex, increased secretions resulting in hypopharyngeal
obstruction, tracheal aspiration, laryngospasm, and apnea/desaturation are the main pathophysiological
mechanisms. Laryngeal, rhinopharyngeal, and oropharyngeal alterations are known to play a significant
role in nasal obstruction and respiratory events. Presently, there is no convincing evidence for GER
in the pathophysiology of SDB in infants aged <12 months, although a relationship between OSAS
and GER has been investigated and suggested [27,28]. Menon and colleagues reported an increased
frequency of apnea in infants with regurgitation, but this was not related to GER [27,29]. Recently,
Kamal et al. reported that newborns with GER had early and late OSA [20]. Our data suggest a
relationship between GER and OSA, although we cannot exclude that GER may be an incidental
finding physiologically present in this cohort of young infants. Laryngeal anomalies also present in
this cohort might explain the observed OSA; however, we cannot ignore the frequency of GER in this
cohort of young infants with OSA.
A limitation of this study was the use of nap PSG, instead of overnight full PSG. Some patients
may have had falsely negative nap PSG. When the parameters of the nap study are abnormal, however,
the probability of OSA is reported to be elevated [30]. Another limitation is that our cohort is a
subgroup analysis. Moreover, we did not present the central apneas and NREM and REM sleep stages,
because it is almost impossible to compare young infants versus older infants, particularly by using
nap-polysomnography recordings. Finally, the low numbers in each subgroup is a limitation and some
of the negative findings were likely due to these low numbers.
Summarizing, the main causative factors of OSA in the young group (age < 1 year) were
laryngomalacia and GER, while tonsillar and adenoidal hypertrophy were more prominent in the
older group (age 1–2 years). Laryngomalacia is commonly associated with GER [31]. In most cases,
the natural history of laryngomalacia is benign, and patients recover spontaneously with time. In 9–29%
of infants, laryngomalacia may result in moderate-severe upper airway obstruction [31]. Adenoid and
tonsillar hyperplasia should be considered in children aged 6 months and older, because it is a frequent
cause of OSAS. [32] In a study involving 28 children (age 1.3–1.8 years), the severity of obstructive
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AHI (7.5–28.3 events/h) was in line with our findings. The majority of these children had adenoid
hypertrophy and tonsillar hyperplasia [11]; however, tonsil/adenoid size does not necessarily predict
the grade of AHI severity [33].
Our data indicate a difference in the main causes of OSA between the two age groups. Increased
tonsil and adenoid size were associated with OSA severity in the older children and laryngomalacia
and GER were associated with OSA severity in the younger children. Our results have potential clinical
utility in evaluating the pathophysiology of OSA in young infants. A multidisciplinary approach may
provide the best strategy to manage young patients with upper airway obstruction.
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Abbreviations
ALTE acute life-threatening event
BRUE brief unexplained event
GER gastroesophageal reflux
ORL otorhinolaryngology
OSA obstructive sleep apnea
PSG polysomnography
SDB sleep disordered breathing
References
1. Tagetti, A.; Bonafini, S.; Zaffanello, M.; Benetti, M.V.; Vedove, F.D.; Gasperi, E.; Cavarzere, P.; Gaudino, R.;
Piacentini, G.; Minuz, P.; et al. Sleep-disordered breathing is associated with blood pressure and carotid
arterial stiffness in obese children. J. Hypertens. 2017, 35, 125–131. [CrossRef] [PubMed]
2. Clinical practice guideline: Diagnosis and management of childhood obstructive sleep apnea syndrome.
Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. American Academy
of Pediatrics. Pediatrics 2002, 1s09, 704–712.
3. Piumelli, R.; Davanzo, R.; Nassi, N.; Salvatore, S.; Arzilli, C.; Peruzzi, M.; Agosti, M.; Palmieri, A.;
Paglietti, M.G.; Nosetti, L.; et al. Apparent Life-Threatening Events (ALTE): Italian guidelines. Ital. J. Pediatr.
2017, 43, 111. [CrossRef] [PubMed]
4. Katz, E.S.; Mitchell, R.B.; D’Ambrosio, C.M. Obstructive sleep apnea in infants. Am. J. Respir. Crit. Care Med.
2012, 185, 805–816. [CrossRef] [PubMed]
5. Don, G.W.; Kirjavainen, T.; Broome, C.; Seton, C.; Waters, K.A. Site and mechanics of spontaneous,
sleep-associated obstructive apnea in infants. J. Appl. Physiol. 2000, 89, 2453–2462. [CrossRef] [PubMed]
6. Walsh, J.H.; Maddison, K.J.; Platt, P.R.; Hillman, D.R.; Eastwood, P.R. Influence of head extension, flexion,
and rotation on collapsibility of the passive upper airway. Sleep 2008, 31, 1440–1447.
7. Carroll, J.L.; McColley, S.A.; Marcus, C.L.; Curtis, S.; Loughlin, G.M. Inability of clinical history to distinguish
primary snoring from obstructive sleep apnea syndrome in children. Chest 1995, 108, 610–618. [CrossRef]
8. Amin, R.S. Gastroesophageal reflux and infant apnea. J. Pediatr. 2000, 137, 298–300. [CrossRef]
9. O’Brien, L.M.; Mervis, C.B.; Holbrook, C.R.; Bruner, J.L.; Klaus, C.J.; Rutherford, J.; Raffield, T.J.; Gozal, D.
Neurobehavioral implications of habitual snoring in children. Pediatrics 2004, 114, 44–49. [CrossRef]
10. Muzumdar, H.; Arens, R. Diagnostic issues in pediatric obstructive sleep apnea. Proc. Am. Thorac. Soc. 2008,
5, 263–273. [CrossRef]
11. Boudewyns, A.; Van de Heyning, P.; Verhulst, S. Drug-induced sedation endoscopy in children <2 years
with obstructive sleep apnea syndrome: Upper airway findings and treatment outcomes. Eur. Arch. Oto
Rhino Laryngol. 2017, 274, 2319–2325. [CrossRef]
Int. J. Environ. Res. Public Health 2020, 17, 3531 8 of 9
12. Greenfeld, M.; Tauman, R.; DeRowe, A.; Sivan, Y. Obstructive sleep apnea syndrome due to adenotonsillar
hypertrophy in infants. Int. J. Pediatr. Otorhinolaryngol 2003, 67, 1055–1060. [CrossRef]
13. Nosetti, L.; Angriman, M.; Zaffanello, M.; Salvatore, S.; Riggi, L.; Niespolo, A.C.; Salvatoni, A.; Agosti, M.
Increased parental perception of sleep disordered breathing in a cohort of infants with ALTE/BRUE events.
Minerva Pediatr. 2018. [CrossRef]
14. Guilleminault, C.; Pelayo, R.; Leger, D.; Philip, P. Apparent life-threatening events, facial dysmorphia and
sleep-disordered breathing. Eur. J. Pediatr. 2000, 159, 444–449. [CrossRef]
15. Piteo, A.M.; Kennedy, J.D.; Roberts, R.M.; Martin, A.J.; Nettelbeck, T.; Kohler, M.J.; Lushington, K. Snoring
and cognitive development in infancy. Sleep Med. 2011, 12, 981–987. [CrossRef]
16. DeHaan, K.L.; Seton, C.; Fitzgerald, D.A.; Waters, K.A.; MacLean, J.E. Polysomnography for the diagnosis
of sleep disordered breathing in children under 2 years of age. Pediatr. Pulmonol. 2015, 50, 1346–1353.
[CrossRef]
17. Berry, R.B.; Budhiraja, R.; Gottlieb, D.J.; Gozal, D.; Iber, C.; Kapur, V.K.; Marcus, C.L.; Mehra, R.;
Parthasarathy, S.; Quan, S.F.; et al. Rules for scoring respiratory events in sleep: Update of the 2007
AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions
Task Force of the American Academy of Sleep Medicine. J. Clin. Sleep Med. 2012, 8, 597–619. [CrossRef]
18. Kaditis, A.G.; Alonso Alvarez, M.L.; Boudewyns, A.; Abel, F.; Alexopoulos, E.I.; Ersu, R.; Joosten, K.;
Larramona, H.; Miano, S.; Narang, I.; et al. ERS statement on obstructive sleep disordered breathing in 1- to
23-month-old children. Eur. Respir. J. 2017, 50, 1700985. [CrossRef]
19. Rabasco, J.; Vigo, A.; Vitelli, O.; Noce, S.; Pietropaoli, N.; Evangelisti, M.; Pia Villa, M. Apparent life-threatening
events could be a wake-up call for sleep disordered breathing. Pediatr. Pulmonol. 2016, 51, 1403–1408.
[CrossRef]
20. Kamal, M.; Tamana, S.K.; Smithson, L.; Ding, L.; Lau, A.; Chikuma, J.; Mariasine, J.; Lefebvre, D.L.;
Subbarao, P.; Becker, A.B.; et al. Phenotypes of sleep-disordered breathing symptoms to two years of age
based on age of onset and duration of symptoms. Sleep Med. 2018, 48, 93–100. [CrossRef]
21. Goncalves, M.T.; Sato, J.; Avelino, M.A.; Pizarro, G.U.; Moreira, G.A.; Hallinan, M.P.; Fujita, R.R.; Wechx, L.L.
Polisomnographic findings on children with laryngopathies. Braz. J. Otorhinolaryngol. 2006, 72, 187–192.
[CrossRef]
22. Vandenplas, Y.; Rudolph, C.D.; Di Lorenzo, C.; Hassall, E.; Liptak, G.; Mazur, L.; Sondheimer, J.; Staiano, A.;
Thomson, M.; Veereman-Wauters, G.; et al. Pediatric gastroesophageal reflux clinical practice guidelines:
Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
(ESPGHAN). J. Pediatr. Gastroenterol. Nutr. 2009, 49, 498–547. [CrossRef] [PubMed]
23. Shin, M.S. Esophageal pH and Combined Impedance-pH Monitoring in Children. Pediatric Gastroenterol.
Hepatol. Nutr. 2014, 17, 13–22. [CrossRef] [PubMed]
24. Mousa, H.; Woodley, F.W.; Metheney, M.; Hayes, J. Testing the association between gastroesophageal reflux
and apnea in infants. J. Pediatr. Gastroenterol. Nutr. 2005, 41, 169–177. [CrossRef]
25. Magista, A.M.; Indrio, F.; Baldassarre, M.; Bucci, N.; Menolascina, A.; Mautone, A.; Francavilla, R.
Multichannel intraluminal impedance to detect relationship between gastroesophageal reflux and apnoea of
prematurity. Dig. Liver Dis. 2007, 39, 216–221. [CrossRef]
26. Davies, I.; Burman-Roy, S.; Murphy, M.S.; Group, G.D. Gastro-oesophageal reflux disease in children:
NICE guidance. BMJ 2015, 350, g7703. [CrossRef]
27. Menon, A.P.; Schefft, G.L.; Thach, B.T. Apnea associated with regurgitation in infants. J. Pediatr. 1985, 106,
625–629. [CrossRef]
28. Arad-Cohen, N.; Cohen, A.; Tirosh, E. The relationship between gastroesophageal reflux and apnea in infants.
J. Pediatr. 2000, 137, 321–326. [CrossRef]
29. Menon, A.P.; Schefft, G.L.; Thach, B.T. Airway protective and abdominal expulsive mechanisms in infantile
regurgitation. J. Appl. Physiol. 1985, 59, 716–721. [CrossRef]
30. Saeed, M.M.; Keens, T.G.; Stabile, M.W.; Bolokowicz, J.; Davidson Ward, S.L. Should children with suspected
obstructive sleep apnea syndrome and normal nap sleep studies have overnight sleep studies? Chest 2000,
118, 360–365. [CrossRef]
31. Simons, J.P.; Greenberg, L.L.; Mehta, D.K.; Fabio, A.; Maguire, R.C.; Mandell, D.L. Laryngomalacia and
swallowing function in children. Laryngoscope 2016, 126, 478–484. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2020, 17, 3531 9 of 9
32. Ramgopal, S.; Kothare, S.V.; Rana, M.; Singh, K.; Khatwa, U. Obstructive sleep apnea in infancy: A 7-year
experience at a pediatric sleep center. Pediatr. Pulmonol. 2014, 49, 554–560. [CrossRef] [PubMed]
33. Hwang, S.H.; Guilleminault, C.; Park, C.S.; Kim, T.W.; Hong, S.C. Usefulness of adenotonsillar size for
prediction of severity of obstructive sleep apnea and flow limitation. Otolaryngol. Head Neck Surg. 2013, 149,
326–334. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
